K/S BIOGRAFERNE I HELSINGØR

 

Quicksearch
from your own companies




Analyst: XBRLDenmark
Estimate generation in progress, please wait...
 
Loading...

Loading...

Loading...

Loading...

 
Loading...

Bankruptcy Risk 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Bankruptcy risk for industry  2.8% 2.8% 2.8% 2.8% 2.8%  
Bankruptcy risk  0.9% 1.4% 1.1% 2.4% 1.1%  
Credit score (0-100)  89 77 82 63 81  
Credit rating  A A A BBB A  
Credit limit (kDKK)  647.6 26.2 266.0 0.0 257.0  

How are these values calculated?
 
View the automatically generated explanation of bankruptcy risk

Income statement (kDKK) 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12

Net sales  0 0 0 0 0  
Gross profit  6,752 3,464 4,421 4,088 5,942  
EBITDA  4,206 1,271 2,702 1,497 2,991  
EBIT  3,568 605 2,080 600 1,346  
Pre-tax profit (PTP)  3,552.8 588.4 2,064.4 474.5 892.0  
Net earnings  3,552.8 588.4 2,064.4 474.5 892.0  
Pre-tax profit without non-rec. items  3,553 588 2,064 475 892  

 
See the entire income statement

Balance sheet (kDKK) 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12

Tangible assets total  5,244 4,578 4,392 12,074 13,427  
Shareholders equity total  5,421 2,456 3,932 2,343 2,760  
Interest-bearing liabilities  0.0 0.0 0.0 4,800 7,834  
Balance sheet total (assets)  8,861 6,316 7,628 16,586 17,482  

Net Debt  -2,669 -1,347 -2,538 1,579 4,684  
 
See the entire balance sheet

Volume 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12

Net sales  0 0 0 0 0  
Net sales growth  0.0% 0.0% 0.0% 0.0% 0.0%  
Gross profit  6,752 3,464 4,421 4,088 5,942  
Gross profit growth  16.5% -48.7% 27.6% -7.5% 45.4%  
Employees  4 4 4 4 7  
Employee growth %  0.0% 0.0% 0.0% 0.0% 75.0%  
Employee expenses  0.0 0.0 0.0 0.0 0.0  
Balance sheet total (assets)  8,861 6,316 7,628 16,586 17,482  
Balance sheet change%  11.4% -28.7% 20.8% 117.4% 5.4%  
Added value  4,205.9 1,271.2 2,702.5 1,221.7 2,990.9  
Added value %  0.0% 0.0% 0.0% 0.0% 0.0%  
Investments  992 -1,332 -808 6,784 -292  

Net sales trend  0.0 0.0 0.0 0.0 0.0  
EBIT trend  4.0 5.0 5.0 5.0 5.0  

Profitability 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
EBITDA %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT to gross profit (%)  52.8% 17.5% 47.1% 14.7% 22.7%  
Net Earnings %  0.0% 0.0% 0.0% 0.0% 0.0%  
Profit before depreciation and extraordinary items %  0.0% 0.0% 0.0% 0.0% 0.0%  
Pre tax profit less extraordinaries %  0.0% 0.0% 0.0% 0.0% 0.0%  
ROA %  42.4% 8.0% 29.8% 5.0% 8.1%  
ROI %  69.0% 15.4% 65.1% 10.8% 15.6%  
ROE %  68.7% 14.9% 64.6% 15.1% 35.0%  

Solidity 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Equity ratio %  61.2% 38.9% 51.6% 14.1% 15.8%  
Relative indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Relative net indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net int. bear. debt to EBITDA, %  -63.5% -105.9% -93.9% 105.5% 156.6%  
Gearing %  0.0% 0.0% 0.0% 204.9% 283.8%  
Net interest  0 0 0 0 0  
Financing costs %  0.0% 0.0% 0.0% 5.2% 7.7%  

Liquidity 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Quick Ratio  1.0 0.4 0.8 0.5 0.3  
Current Ratio  1.1 0.5 0.9 0.5 0.4  
Cash and cash equivalent  2,668.9 1,346.7 2,537.9 3,221.4 3,150.1  

Capital use efficiency 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Trade debtors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Trade creditors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Current assets / Net sales %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net working capital  176.7 -2,121.5 -459.9 -4,931.0 -6,666.7  
Net working capital %  0.0% 0.0% 0.0% 0.0% 0.0%  

Employee efficiency 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Net sales / employee  0 0 0 0 0  
Added value / employee  1,051 318 676 305 427  
Employee expenses / employee  0 0 0 0 0  
EBITDA / employee  1,051 318 676 374 427  
EBIT / employee  892 151 520 150 192  
Net earnings / employee  888 147 516 119 127